| Category | BioTech |
| Phone | 510-252-9500 |
| Employees | |
| Founded | 2002 |
| TOTAL | $15M |
| FUNDING TOTAL | $15M |
| Series D, 11/05 De Novo Ventures Palo Alto Investors ABN AMRO Private Equity Medica Venture Partners Oxford Bioscience Partners | $15M |
FlowMedica a medical device company, produces intravascular systems for implementing Targeted Renal Therapy. The company offers Benephit CV Infusion System that provides physician-specified therapeutic agents directly into the renal arteries through an infusion catheter while allowing simultaneous coronary procedures through a single vessel access site in the femoral artery; and Benephit XTMini Infusion System that allows for bilateral infusion to the kidneys in patients with smaller vascular anatomies.
